INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Total Expenditure History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹85 Cr | ₹62 Cr | ₹52 Cr | ₹43 Cr | ₹35 Cr |
What is the latest Total Expenditure of INDO US BIOTECH ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹85 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹35 Cr |
How is Total Expenditure of INDO US BIOTECH Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹85 Cr | 36.87 | |
| Mar2024 | ₹62 Cr | 18.49 | |
| Mar2023 | ₹52 Cr | 21.40 | |
| Mar2022 | ₹43 Cr | 24.73 | |
| Mar2021 | ₹35 Cr | - | |
Compare Total Expenditure of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹265.4 Cr | 1.2% | 6.6% | -41.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,502.8 Cr | 2.1% | -0.2% | -13.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,484.2 Cr | 1.4% | 0.4% | -9.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,026.1 Cr | -8.1% | -10.5% | -19.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹956.0 Cr | -2.6% | -10.1% | -42% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹399.4 Cr | 3.1% | -1.8% | -12.1% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 1.2% |
6.6% |
-41.3% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses